F.N.B. Corporation Common Stock (FNB)

Long-Term Investments

$46.58B

Quarterly · Period ending: · USD

FNB logo

FNB Long-Term Investments

Latest reported$46.58B
FNB Quarterly Long-Term Investments ($1.01B → $46.58B)
High-resolution chart · PNG

FNB long-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

F.N.B. Corporation Common Stock Long-Term Investments — Quarterly (USD)
Period endingLong-Term Investments (USD)
46,581,000,000
45,572,000,000
45,158,000,000
4,117,000,000
38,545,300,000
38,389,900,000
37,705,800,000
37,461,000,000
36,622,600,000
36,680,000,000
35,563,000,000
35,737,000,000
35,220,000,000
34,405,000,000
33,881,000,000
33,558,800,000
31,861,000,000
31,066,000,000
29,763,000,000
27,901,400,000
27,333,000,000
27,589,000,000
27,944,000,000
27,650,000,000
28,475,000,000
28,458,000,000
26,345,000,000
25,987,000,000
25,707,000,000
25,381,000,000
25,268,000,000
24,876,000,000
24,563,371,000
24,484,804,000
24,065,550,000
23,892,000,000
23,508,395,000
23,385,477,000
22,817,219,000
16,891,498,000
16,688,388,000
16,284,776,000
15,598,897,000
13,485,717,000
13,068,197,000
12,829,536,000
12,613,218,000
12,402,823,000
12,155,627,000
11,483,006,000
11,093,809,000
10,442,722,000
9,774,236,000
9,561,636,000
9,106,511,000
9,037,526,000
10,162,893,000
10,051,373,000
9,988,676,000
7,576,697,000
8,476,690,000
8,434,812,000
8,219,529,000
7,673,341,000
7,513,272,000
7,472,785,000
7,310,047,000
7,248,090,000
7,247,951,000
7,097,126,000
7,042,722,000
7,052,491,000
7,143,782,000
6,827,361,000
5,410,561,000
5,323,040,000
5,349,572,000
5,284,519,000
5,249,525,000
5,238,882,000
5,279,961,000
5,278,448,000
4,912,570,000
4,907,506,000
5,042,452,000
5,039,464,000
4,963,473,000
4,521,813,000
4,318,402,000
4,331,706,000
4,214,886,000
4,117,190,000
7,258,955,000
7,261,850,000
7,088,160,000
6,251,458,000
6,145,623,000
5,939,222,000
5,778,602,000
5,705,037,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.